In part 2 of this Q and A, Brittany Albright, MD, MPH, founder and CEO of Sweetgrass Psychiatry, discusses 2 of her favorite strategies for treating patients who have anhedonia.
In this Q&A, Dr Brittany Albright sheds light on the pervasive and challenging symptom of anhedonia, which can have profound implications on patients’ quality of life, clinical outcomes, and societal...
In part 2 of this Q and A, Brittany Albright, MD, MPH, founder and CEO of Sweetgrass Psychiatry, discusses 2 of her favorite strategies for treating patients who have anhedonia.
In this Q&A, Dr Brittany Albright sheds light on the pervasive and challenging symptom of anhedonia, which can have profound implications on patients’ quality of life, clinical outcomes, and societal...
Following depression screenings, moderate rates of treatment initiation among patients with elevated depressive symptoms and/or suicidal ideation (SI) were found, particularly for those in more-vulnerable...
Esketamine (ESK) nasal spray monotherapy was found to be efficacious over placebo in adults with treatment-resistant depression, according to recent randomized, double-blind study results reported in a...
Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...
Chronic pain in youth was associated with an increased risk of anxiety and depression, particularly when compared to symptoms of youth without chronic pain. Results from the systematic review and...
Increases in depressive symptoms during adolescence can persist into young adulthood, according to recent cohort study results published in JAMA Network Open.
